BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31998559)

  • 1. A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients.
    Yang W; Qi YB; Si M; Hou Y; Nie L
    PeerJ; 2020; 8():e8389. PubMed ID: 31998559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma.
    Lian H; Zhou Y; Sun Z; Liu K
    Medicine (Baltimore); 2022 Sep; 101(38):e30722. PubMed ID: 36197268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study.
    Wang X; Zhang Y; Zhi X
    Thorac Cancer; 2017 Sep; 8(5):511-516. PubMed ID: 28727276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
    Mirghasemi A; Taheriazam A; Karbasy SH; Torkaman A; Shakeri M; Yahaghi E; Mokarizadeh A
    Cancer Cell Int; 2015; 15():86. PubMed ID: 26388701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis.
    Luo H; Wang P; Ye H; Shi J; Dai L; Wang X; Song C; Zhang J; Li J
    Front Genet; 2020; 11():789. PubMed ID: 32849795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
    Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
    J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
    Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
    BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
    Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
    Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
    Lee RJ; Arshi A; Schwartz HC; Christensen RE
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
    Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
    J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
    Tian F; Xu J; Xue F; Guan E; Xu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
    Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
    Hui WT; Ma XB; Zan Y; Wang XJ; Dong L
    Chin Med J (Engl); 2015 Oct; 128(19):2632-7. PubMed ID: 26415802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
    Chen YL; Liu XL; Li L
    BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.